Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema

Polymorphic variants of B2 receptors for bradykinin (B2BKR) have been postulated to influence a clinical manifestation of hereditary angioedema. In this study, exon 1 nonanucleotide deletion polymorphism in the B2BKR gene was examined in 37 patients with hereditary angioedema. The patients were grou...

Full description

Saved in:
Bibliographic Details
Published in:Human immunology Vol. 63; no. 6; pp. 492 - 494
Main Authors: Freiberger, Tomáš, Vyskočilová, Martina, Kolářová, Lenka, Kuklínek, Pavel, Kryštůfková, Olga, Lahodná, Marie, Hanzlíková, Jana, Litzman, J.iří
Format: Journal Article
Language:English
Published: United States Elsevier Inc 01-06-2002
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Polymorphic variants of B2 receptors for bradykinin (B2BKR) have been postulated to influence a clinical manifestation of hereditary angioedema. In this study, exon 1 nonanucleotide deletion polymorphism in the B2BKR gene was examined in 37 patients with hereditary angioedema. The patients were grouped according to disease severity or the age of the first clinical manifestation of disease. No significant differences in allelic frequencies were found between particular subgroups of patients. Therefore, we concluded that this polymorphism does not seem to have any significant effect on the course and severity of hereditary angioedema in Caucasians.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0198-8859
1879-1166
DOI:10.1016/S0198-8859(02)00397-X